Moderna raises full-year COVID vaccine sales forecast to $21 billion

1 min read
FILE PHOTO: FILE PHOTO: FILE PHOTO: Vial and sryinge are seen in front of displayed Moderna logo

– Moderna Inc on Thursday raised its full-year forecast for sales of its COVID-19 vaccine to roughly $21 billion from $19 billion.

The company in February forecast sales of $19 billion from its signed contracts, and option for $3 billion in additional purchases.

Moderna on Thursday forecast additional purchases of roughly $500 million.

(Reporting by Manas Mishra in Bengaluru)


Breaking News
Exclusive-Heir to McDonald's Russia craves success but Big Mac a 'big loss'